Long Island Jewish Medical Center — New Hyde Park, New York

Public research footprint of Long Island Jewish Medical Center, compiled from the ClinicalTrials.gov public registry.

274

Registered studies

Active

Recruiting now

171

Completed

Stopped or withdrawn

Most-studied conditions

B Acute Lymphoblastic Leukemia · Recurrent Endometrial Dedifferentiated Carcinoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Lip and Oral Cavity Squamous Cell Carcinoma

Recently updated registry entries

NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT02003222 — Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Long Island Jewish Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.